Objective Diagnosis of Fibromyalgia Using Neuroretinal Evaluation and Artificial Intelligence, 2022, Boquetea et al

Discussion in ''Conditions related to ME/CFS' news and research' started by Andy, Mar 16, 2022.

  1. Andy

    Andy Committee Member

    Messages:
    22,398
    Location:
    Hampshire, UK
    Abstract

    Background/Objective
    This study aims to identify objective biomarkers of fibromyalgia (FM) by applying artificial intelligence algorithms to structural data on the neuroretina obtained using swept-source optical coherence tomography (SS-OCT).

    Method
    The study cohort comprised 29 FM patients and 32 control subjects. The thicknesses of complete retina, 3 retinal layers [ganglion cell layer (GCL+), GCL++ (between the inner limiting membrane and the inner nuclear layer boundaries) and retinal nerve fiber layer (RNFL)] and choroid in 9 areas around the macula were obtained using SS-OCT. Discriminant capacity was evaluated using the area under the curve (AUC) and the Relief algorithm. A diagnostic aid system with an automatic classifier was implemented.

    Results
    No significant difference (p ≥ .660) was found anywhere in the choroid. In the RNFL, a significant difference was found in the inner inferior region (p = .010). In the GCL+, GCL++ layers and complete retina, a significant difference was found in the 4 regions defining the inner ring: temporal, superior, nasal and inferior. Applying an ensemble RUSBoosted tree classifier to the features with greatest discriminant capacity achieved accuracy = .82 and AUC = .82.

    Conclusions
    This study identifies a potential novel objective and non-invasive biomarker of FM based on retina analysis using SS-OCT.

    Open access, https://www.sciencedirect.com/science/article/pii/S1697260022000035
     

Share This Page